# Verseau Therapeutics, Inc. — Form D

Verseau Therapeutics, Inc. of Auburndale, MA, a company, filed a Form D exempt-offering notice with the SEC on 2017-03-30. The offering totals $11.4M, of which $4.3M was reported sold. Industry: Other Health Care.

## Offering

- Filed: 2017-03-30
- Form: D
- Accession: 0001701272-17-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $11.4M
- Amount sold: $4.3M
- Remaining: $7.2M
- Investors: 5
- Date of first sale: 2017-03-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-283695

## Issuer

- Name: Verseau Therapeutics, Inc.
- CIK: 0001701272
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 2000 Commonwealth Avenue, Auburndale, MA, 02466
- Phone: 617-244-9050

## Officers, directors & promoters (9)

| Name | Role | Location |
| --- | --- | --- |
| Daniel Anderson | Director | Brea, CA |
| Christine Bunt | Director | Fair Haven, NJ |
| Jong Chang | Director | Auburndale, MA |
| Robert Langer | Director | Pittsburgh, PA |
| Daniel Anderson | Executive Officer | Brea, CA |
| Christine Bunt | Executive Officer | Fair Haven, NJ |
| Walter Capone | Executive Officer | Auburndale, MA |
| Daniel Anderson | Promoter | Brea, CA |
| Robert Langer | Promoter | Pittsburgh, PA |

## More

- [CIK 1701272 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1701272&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001701272-17-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.